JP2022511126A5 - - Google Patents
Info
- Publication number
- JP2022511126A5 JP2022511126A5 JP2021551329A JP2021551329A JP2022511126A5 JP 2022511126 A5 JP2022511126 A5 JP 2022511126A5 JP 2021551329 A JP2021551329 A JP 2021551329A JP 2021551329 A JP2021551329 A JP 2021551329A JP 2022511126 A5 JP2022511126 A5 JP 2022511126A5
- Authority
- JP
- Japan
- Prior art keywords
- cell lymphoma
- pharmaceutical composition
- effective amount
- treatment
- combination
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811394614.7 | 2018-11-20 | ||
| CN201811394614 | 2018-11-20 | ||
| PCT/CN2019/119170 WO2020103788A1 (zh) | 2018-11-20 | 2019-11-18 | 西达本胺联合r-chop的应用及联合药物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022511126A JP2022511126A (ja) | 2022-01-28 |
| JP2022511126A5 true JP2022511126A5 (enExample) | 2022-08-24 |
| JP7489397B2 JP7489397B2 (ja) | 2024-05-23 |
Family
ID=70741744
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021551329A Active JP7489397B2 (ja) | 2018-11-20 | 2019-11-18 | Ｒ－ｃｈｏｐとの組み合わせ及び複合薬におけるチダミドの適用 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US12194054B2 (enExample) |
| EP (1) | EP3884943B1 (enExample) |
| JP (1) | JP7489397B2 (enExample) |
| KR (1) | KR102958344B1 (enExample) |
| CN (2) | CN111195249B (enExample) |
| AU (1) | AU2019385373B2 (enExample) |
| BR (1) | BR112021009627A2 (enExample) |
| MY (1) | MY209036A (enExample) |
| PH (1) | PH12021551138A1 (enExample) |
| SG (1) | SG11202105137RA (enExample) |
| TW (1) | TWI768263B (enExample) |
| WO (1) | WO2020103788A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113813268A (zh) * | 2020-06-18 | 2021-12-21 | 苏州亚盛药业有限公司 | 包含Bcl-2抑制剂或Bcl-2/Bcl-xL抑制剂的组合产品及其用途 |
| CN112274509B (zh) * | 2020-12-02 | 2022-04-26 | 四川大学华西医院 | 西达本胺联合bcl2抑制剂在双表达型b细胞淋巴瘤中的应用 |
| CN118593502B (zh) * | 2024-05-24 | 2026-08-04 | 厦门大学附属第一医院 | 一种预防或治疗tp53突变双打击淋巴瘤的联合用药物组合物及其应用 |
| CN121513004B (zh) * | 2026-01-14 | 2026-04-03 | 首都医科大学附属北京友谊医院 | 一种治疗abc型弥漫性大b细胞淋巴瘤的组合物及其应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1974747E (pt) * | 1998-08-11 | 2012-09-05 | Biogen Idec Inc | Terapias de combinação para linfomas de células b compreendendo a administração de anticorpo anti-cd20 |
| HRP20060080A2 (en) * | 2003-08-26 | 2006-07-31 | Sloan-Kettering Institute For Cancer Research | Method of treating cancer with hdac inhibitors |
| CN101146548A (zh) * | 2005-02-15 | 2008-03-19 | 诺华疫苗和诊断公司 | 化疗药、il-2和任选的抗cd20抗体联用治疗淋巴瘤的方法 |
| CN101470112A (zh) * | 2007-12-28 | 2009-07-01 | 上海交通大学医学院附属瑞金医院 | 弥漫性大b细胞淋巴瘤治疗指导和预后判断的分子标志物 |
| CN103833626B (zh) | 2012-11-27 | 2015-11-25 | 深圳微芯生物科技有限责任公司 | 西达本胺的晶型及其制备方法与应用 |
| TWI808055B (zh) * | 2016-05-11 | 2023-07-11 | 美商滬亞生物國際有限公司 | Hdac 抑制劑與 pd-1 抑制劑之組合治療 |
| MX2019000864A (es) | 2016-07-20 | 2019-06-03 | Univ Columbia | Activadores de histona acetiltransferasa y sus composiciones y usos. |
| CN107157978B (zh) * | 2017-05-24 | 2021-06-18 | 中国药科大学 | 治疗ebv+dlbcl和dlbcl的药物及组合物 |
| CN108743947B (zh) * | 2018-07-04 | 2020-12-15 | 复旦大学附属肿瘤医院 | 一种治疗b细胞淋巴瘤的药物组合物 |
-
2019
- 2019-03-25 CN CN201910228406.8A patent/CN111195249B/zh active Active
- 2019-03-25 CN CN202311474046.2A patent/CN117797149A/zh active Pending
- 2019-11-18 MY MYPI2021002751A patent/MY209036A/en unknown
- 2019-11-18 AU AU2019385373A patent/AU2019385373B2/en active Active
- 2019-11-18 SG SG11202105137RA patent/SG11202105137RA/en unknown
- 2019-11-18 KR KR1020217018968A patent/KR102958344B1/ko active Active
- 2019-11-18 JP JP2021551329A patent/JP7489397B2/ja active Active
- 2019-11-18 TW TW108141826A patent/TWI768263B/zh active
- 2019-11-18 US US17/295,494 patent/US12194054B2/en active Active
- 2019-11-18 BR BR112021009627-2A patent/BR112021009627A2/pt unknown
- 2019-11-18 WO PCT/CN2019/119170 patent/WO2020103788A1/zh not_active Ceased
- 2019-11-18 EP EP19887480.2A patent/EP3884943B1/en active Active
-
2021
- 2021-05-19 PH PH12021551138A patent/PH12021551138A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6812360B2 (ja) | 嘔気嘔吐を治療するためのアミスルプリドと他の制吐薬との併用 | |
| JP2023541430A5 (enExample) | ||
| RU2010147287A (ru) | Комбинированная композиция | |
| JP2006504795A5 (enExample) | ||
| TW201210593A (en) | Compositions and methods for treating centrally mediated nausea and vomiting | |
| EA201590166A8 (ru) | Комбинированная терапия для лечения рассеянного склероза | |
| US20110281833A1 (en) | Composition for the Treatment of Ear Infections and Method | |
| RU2019107011A (ru) | Композиции апилимода и способы их применения | |
| JP2010538066A5 (enExample) | ||
| JP2019511506A5 (enExample) | ||
| CN102438608A (zh) | 包含ave8062和索拉非尼的抗肿瘤组合 | |
| JP7489397B2 (ja) | Ｒ－ｃｈｏｐとの組み合わせ及び複合薬におけるチダミドの適用 | |
| JP2022502498A5 (enExample) | ||
| ES2656913T3 (es) | Endrogenina A y agentes antineoplásicos para el tratamiento de tumores quimiosensibles o quimiorresistentes | |
| JP2016505050A5 (enExample) | ||
| RU2014148977A (ru) | Обработка популяции рыб луфенуроном | |
| US3011945A (en) | Phenylcyclopropylamine -10-(omega-aminoalkyl)-phenothiazine ataractic composition | |
| CN102784159A (zh) | 兽用注射用复方增效酒石酸泰乐菌素 | |
| JP2021511352A5 (enExample) | ||
| RU2013126798A (ru) | Комбинированная терапия дексаметазоном | |
| JP2017530142A5 (enExample) | ||
| RU2021114295A (ru) | Применение хидамида в комбинации с R-CHOP и комбинация лекарственных средств | |
| EP3010508B1 (en) | Combination of ro5503781, capecitabine and oxaliplatin for cancer therapy | |
| JP2025522146A5 (enExample) | ||
| JP2023549605A5 (enExample) |